| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.88B | 37.71B | 35.33B | 33.27B | 28.54B | 21.56B |
| Gross Profit | 21.55B | 22.50B | 21.59B | 20.38B | 17.51B | 12.99B |
| EBITDA | 3.33B | 3.35B | 3.67B | 3.21B | 1.30B | -2.56B |
| Net Income | 1.46B | 1.27B | 1.74B | 1.31B | 132.00M | 627.00M |
Balance Sheet | ||||||
| Total Assets | 28.79B | 29.65B | 27.87B | 27.25B | 24.90B | 24.59B |
| Cash, Cash Equivalents and Short-Term Investments | 8.46B | 9.29B | 9.85B | 9.98B | 9.95B | 9.31B |
| Total Debt | 1.76B | 1.64B | 1.34B | 1.12B | 588.00M | 701.00M |
| Total Liabilities | 6.64B | 0.00 | 5.93B | 6.35B | 4.83B | 4.44B |
| Stockholders Equity | 22.14B | 22.52B | 21.94B | 20.89B | 20.07B | 20.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 0.00 | 888.00M | 2.28B | 917.00M | 431.00M |
| Operating Cash Flow | 0.00 | 0.00 | 2.71B | 3.53B | 2.03B | 1.17B |
| Investing Cash Flow | 0.00 | 0.00 | 54.00M | -1.62B | -1.10B | -808.00M |
| Financing Cash Flow | 0.00 | 0.00 | -892.00M | -679.00M | -311.00M | -282.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ¥21.80B | 20.09 | ― | ― | ― | ― | |
69 Neutral | ¥40.56B | 35.22 | ― | 1.35% | 11.02% | -0.61% | |
68 Neutral | ¥36.47B | 11.79 | ― | 0.94% | 9.00% | -3.45% | |
65 Neutral | ¥41.36B | 3.96 | ― | 1.04% | 5.47% | 61.89% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥29.69B | 22.62 | ― | 2.47% | 2.93% | -8.37% | |
46 Neutral | ¥43.77B | 104.89 | ― | 0.62% | 13.05% | -29.04% |